← Eichor
Condition: Alzheimer Blood Biomarkers Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Alzheimer Blood Biomarkers

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline an
Phase N/A · 3 location(s) · Istituto Nazionale di Ricovero e Cura per Anziani · NCT07435467
Impact of a Multimodal Lifestyle Intervention on Dementia Risk Factors and Attitude Related to Dementia Risk: A Logistic
NA · 1 location(s) · HudsonAlpha Institute for Biotechnology · NCT07146412
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Diseas
NA · 8 location(s) · Alzheimercentrum Amsterdam · NCT07680335
Blood-based Biomarkers for Alzheimer's Disease at the Primary Care Level.
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07666113
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
Phase N/A · 1 location(s) · MoCA Clinic and Institute · NCT07041450
TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics.
Phase N/A · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT07399418
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3 · 5 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07234695
Study to Understand Novel Biomarkers in Researching Dementia
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06547099
Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis
Phase N/A · 2 location(s) · Monash University · NCT06339190
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT07236190
Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in
NA · 1 location(s) · University of Bern · NCT06669546
Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Phase N/A · 5 location(s) · Neurogen Biomarking LLC · NCT07701161
Blood-based Biomarkers for Diagnosis of Alzheimer's
NA · 1 location(s) · Helse Stavanger HF · NCT05187819
Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT07482072
Predicting Pre-dementia
Phase N/A · 1 location(s) · Prevention Research Consortium Corp. · NCT07516119
The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)
Phase N/A · 1 location(s) · Imperial College London · NCT05885295
Community-based Screening for Alzheimer's Disease
Phase N/A · 4 location(s) · Kuang XiaoJun · NCT07570719
Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT07717567
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
NA · 1 location(s) · Pennington Biomedical Research Center · NCT07265323
The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
Phase N/A · 1 location(s) · Capital Medical University · NCT05020106
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
Phase 2 · 1 location(s) · Michal Schnaider Beeri, Ph.D. · NCT07392723
The Swedish BioFINDER - Primary Care Study
Phase N/A · 1 location(s) · Skane University Hospital · NCT06120361
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PE
Phase N/A · 26 location(s) · GAP Innovations, PBC · NCT06584357
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
NA · 1 location(s) · Johns Hopkins University · NCT05795634
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
Phase N/A · 2 location(s) · First Affiliated Hospital of Zhejiang University · NCT07153848
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.